Ask Warren

Curocell

372320 · KOSDAQ · ₩372320 · 큐로셀

₩25,000▲ ₩600 (2.46%)End-of-day · Oct 28, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩0₩0₩0₩0₩0₩0₩0₩0
Cost of sales₩2.7B₩0₩0₩0₩0₩0₩0₩0
Gross profit−₩2.7B₩0₩0₩0₩0₩0₩0₩0
Operating income−₩9.7B−₩7.8B−₩8.7B−₩9.2B−₩12B−₩6.2B−₩10B−₩10B
Net income−₩18B−₩8.7B−₩18B−₩10B−₩12B−₩6.8B−₩10B−₩10B
Net income to shareholders−₩18B−₩8.7B−₩18B−₩10B−₩12B−₩6.8B−₩10B−₩10B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩165B₩101B₩110B₩113B₩111B₩101B₩72B₩81B
Current assets₩90B₩25B₩32B₩35B₩32B₩38B₩13B₩22B
Cash and equivalents₩17B₩4B₩10B₩19B₩9.2B₩4.4B₩4.6B₩8.7B
Total liabilities₩92B₩76B₩105B₩93B₩82B₩78B₩43B₩43B
Current liabilities₩49B₩69B₩97B₩84B₩74B₩37B₩39B₩37B
Borrowings₩59B₩46B₩55B₩54B₩49B₩61B₩35B₩37B
Total equity₩73B₩25B₩5B₩20B₩29B₩23B₩29B₩38B
Shareholders' equity₩73B₩25B₩5B₩20B₩29B₩23B₩29B₩38B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations−₩7.6B−₩7.8B−₩6.5B−₩8.1B−₩9.6B−₩5.8B−₩7.5B−₩8.2B
Capital spending₩91M₩70M₩86M₩63M₩144M₩20M−₩256M₩149M
Free cash flow−₩7.7B−₩7.9B−₩6.6B−₩8.1B−₩9.8B−₩5.9B−₩7.7B−₩8.4B

Consolidated where available. Amounts in won.

Also known as: Curocell / 큐로셀 / 372320 / KRX:372320

Source: KRX statistical information